Back

Prostaglandin E1 attenuates AngII-induced cardiac hypertrophy via EP3 receptor activation and Netrin-1upregulation

27 August 2021 (08:00 - 20:00)
Organised by:
Congress Presentation Part of: Basic science e-posters Cardiac Hypertrophy ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Yejiao Shen

Shanghai (China)

202 More presentations in this session

Presentation thumbnail
Monounsaturated fatty acid antagonizes saturated fatty acid-induced cardiomyopathy via improving membrane fatty acid composition and endoplasmic reticulum stress
Doctor T. Yamamoto (Tokyo, JP)
Abstract Slides
Presentation thumbnail
MicroRNA let-7a, -7e and -133a attenuate hypoxia-induced atrial fibrosis via targeting collagen expression and the JNK pathway in HL1 cardiomyocytes
Doctor C. Lo (Miaoli, TW)
Abstract Slides
Presentation thumbnail
Acute administration of the olive constituent, oleuropein, combined with post-conditioning mechanism exerts cardioprotective effects by modulating oxidative defense
Professor I. Andreadou (Athens, GR)
Abstract Slides
Presentation thumbnail
Coronary artery cavitation as a trigger for atherosclerotic plaque progression: a numerical and computational fluid dynamic demonstration
Associate Professor G. Rigatelli (Rovigo, IT)
Abstract Slides
Presentation thumbnail
Melatonin receptor blockade slows ventricular conduction by IK1 downregulation
Doctor M. Gonotkov (Syktyvkar, RU)
Abstract Slides

Access the full session

Session thumbnail
Basic science e-posters

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August 2021 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Therapeutic role of Prostaglandin E2 receptor 4 stimulation in inflammatory cardiomyopathy
30 August 2021
thumbnail
Congress Presentation
Shear stress-induced endothelial HEG1 signaling regulates vascular tone and blood pressure
31 August 2025
thumbnail
Congress Presentation
Mapping the proteomic and human genomic bridge of the cardiac Striatin interactome identifies unique molecular signature between diabetes and heart remodeling
1 September 2025
thumbnail
Congress Presentation
Real-life evidence of the use of subcutaneous treprostinil in pulmonary hypertension in Argentina
1 July 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources